|
[1]RATZIU V, GIRAL P, CHARLOTTE F, et al.Liver fibrosis in overweigh patients[J].Gastroenterology, 2000, 118 (6) :1117-1123.
|
|
[2]GAGGINI M, MORELLI M, BUZZIGOLI E, et al.Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease[J].Nutrients, 2013, 5 (5) :1544-1560
|
|
[3]WREE A, BRODERICK L, CANBAY A, et al.From NAFLD to NASH to cirrhosis new insights into disease mechanisms[J].Nat Rev Gastroenterol Hepatol, 2013, 10 (11) :627-636.
|
|
[4]DOWMAN JK, TOMLINSON JW, NEWSOME PN.Pathogenesis of non-alcoholic fatty liver disease[J].QJM, 2010, 103 (2) :71-83.
|
|
[5]STARLEY BQ, CALCAGNO CJ, HARRISON SA.Nonalcoholic fatty liver disease and hepatocellular carcinoma:a weighty connection[J].Hepatology, 2010, 51 (5) :1820-1832.
|
|
[6]ANSTEE QM, GOLDIN RD.Mouse models in non-alcoholic fatty liver disease and steatohepatitis research[J].Int J Exp Pathol, 2006, 87 (1) :1-16.
|
|
[7]NIETO-VAZQUEZ I, FERNNDEZ-VELEDO S, KRMER DK, et al.Insulin resistance associated to obesity:the link TNF-alpha[J].Arch Physiol Biochem, 2008, 114 (3) :183-194.
|
|
[8]LIEBER CS, LEO MA, MAK KM, et al.Model of nonalcoholic steatohepatitis[J].A J Clin Nutr, 2004, 79 (3) :502-509.
|
|
[9]ECCLESTON HB, ANDRINGA KK, BETANCOUNRT AM, et al.Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxidebioavailability, and modifies the mitochondrial proteome in mice[J].Antioxid Redox Signal, 2011, 15 (2) :447-459.
|
|
[10]LAU JK, ZHANG X, YU J.Animal models of non-alcoholic fatty liver disease:current perspectives and recent advances[J].JPathol, 2017, 241 (1) :36-44.
|
|
[11]FAKHOURY-SAYEGH N, TRAK-SMAYRA V, KHAZZAKAA, et al.Characteristics of nonalcoholic fatty liver disease induced in wistar rats following four different diets[J].Nutr Res Pract, 2015, 9 (4) :350-357.
|
|
[12]JIN J, VALANEJAD L, NGUYEN TP, et al.Activation of CDK4 triggers development of non-alcoholic fatty liver disease[J].Cell Rep, 2016, 16 (3) :744-756.
|
|
[13]XIA SF, LE GW, WANG P, et al.Regressive effect of myricetin on hepatic steatosis in mice fed a high-fat diet[J].Nutrients, 2016, 8 (12) :799.
|
|
[14]TRAK-SMAYRA V, PARADIA V, MASSART J, et al.Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet[J].Int J Exp Pathol, 2011, 92 (6) :413-421.
|
|
[15]YANG SQ, LIN HZ, LANE MD, et al.Obesity increases sensitivity to endotoxin liver injury:implications for the pathogenesis of steatohepatitis[J].Proc Natl Acad Sci U S A, 1997, 94 (6) :2557-2562.
|
|
[16]SAHAI A, MALLADI P, PAN X, et al.Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis:role of short-form leptin receptors and osteopontin[J].Am J Physiol Gastrointest Liver Physiol, 2004, 287 (5) :g1035-g1043.
|
|
[17]PAZ-FILHO G, MASTROARDI C, DELIBASI T, et al.Congenital leptin deficiency:diagnosis and effects of leptin replacement therapy[J].Arq Bras Endocrinol Metabol, 2010, 54 (8) :690-697.
|
|
[18]LI Y, ZALZALA M, JADHAV K, et al.Carboxylesterase 2 prevents liver by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice[J].Hepatology, 2016, 63 (6) :1860-1874.
|
|
[19]FARRELL GC, LARTER CZ.Nonalcoholic fatty liver disease:from steatosis to cirrhosis[J].Hepatology, 2006, 43 (2 Suppl 1) :s99-s112.
|
|
[20]GANZ M, SZABO G.Immune and inflammatory pathways in NASH[J].Hepatol Int, 2013, 7 (suppl 2) :771-781.
|
|
[21]TAKAHASHI Y, SOEJIMA Y, FUKUSATO T.Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J].World J Gastroenterol, 2012, 18 (19) :2300-2308.
|
|
[22]DAY CP, JAMES OF.Steatohepatitis:a tale of two‘hits’?[J].Gastroenterology, 1998, 114 (4) :842-845.
|
|
[23]TILG H, MOSCHEN AR.Evolution of inflammation in nonalcoholic fatty liver disease:the multiple parallel hits hypothesis[J].Hepatology, 2010, 52 (5) :1836-1846.
|
|
[24]MEDINA J, FERNANDEZ-SALAZAR LI, GARCIA-BUEY L, et al.Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis[J].Diabetes Care, 2004, 27 (8) :2057-2066.
|
|
[25]CORBIN KD, ZEISEL SH.Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression[J].Curr Opin Gastroenterol, 2012, 28 (2) :159-165.
|
|
[26]YAMADA T, OBATA A, KASHIWAGI Y, et al.Gd-EOB-DT-PA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice[J].Magn Reson Imaging, 2016, 34 (6) :724-729.
|
|
[27]MACHADO MV, MICHELOTTI GA, XIE G, et al.Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease[J].PLo S One, 2015, 10 (6) :e0127991.
|
|
[28]YAMAMOTO T, NAKADE Y, YAMAUCHI T, et al.Glucagonlike peptide analogue prevents nonalcoholic steatohepatitis in nonobese mice[J].World J Gastroenterol, 2016, 22 (8) :2512-2523.
|
|
[29]RINELLA ME, GREEN RM.The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance[J].J Hepatol, 2004, 40 (1) :47-51.
|
|
[30]KANURI G, BERGHEIM I.In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD) [J].Int J Mol Sci, 2013, 14 (6) :11963-11980.
|
|
[31]SUBRAMANIAN S, GOODSPEED L, WANG S, et al.Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice[J].J Lipid Res, 2011, 52 (9) :1626-1635.
|
|
[32]SAVARD C, TARATAGLIONE EV, KUVER R, et al.Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis[J].Hepatology, 2013, 57 (1) :81-92.
|
|
[33]KOHLI R, KIRBY M, XANTHAKOS SA, et al.High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis[J].Hepatology, 2010, 52 (3) :934-944.
|
|
[34]ZHANG X, HAN J, MAN K, et al.CXC chemokine receptor 3promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy[J].J Hepatol, 2016, 64 (1) :160-170.
|
|
[35]BELL-ANDERSON KS, AOUAD L, WILLIAMS H, et al.Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice[J].Int J Obes (Lond) , 2011, 35 (12) :1539-1548.
|
|
[36]FARRELL GC, MRIDHA AR, YEH MM, et al.Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype[J].Liver Int, 2014, 34 (7) :1084-1093.
|
|
[37]HANDA P, MORGAN-STEVENSON V, MALIKEN BD, et al.I-ron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice[J].Am J Physiol Gastrointest Liver Physiol, 2016, 310 (2) :g117-g127.
|
|
[38]BRUNT EM, TINIAKOS DG.Histopathology of nonalcoholic fatty liver disease[J].World J Gastroenterol, 2010, 16 (42) :5286-5296.
|
|
[39]HEINDRYCKX F, COLLE I, van VLIERBERGHE H.Experimental mouse models for hepatocellular carcinoma research[J].Int JExp Pathol, 2009, 90 (4) :367-386.
|
|
[40]WOLF MJ, ADILI A, PIOTROWITZ K, et al.Metabolic activation of intrahepatic CD8+T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes[J].Cancer Cell, 2014, 26 (4) :549-564.
|
|
[41]de MINICIS S, AGOSTINELLI L, RYCHLICKI C, et al.HCC development is associated to peripheral insulin resistance in a mouse model of NASH[J].PLo S One, 2014, 9 (5) :e97136.
|
|
[42]ASGHARPOUR A, CAZANAVE SC, PACANA T, et al.A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer[J].J Hepatol, 2016, 65 (3) :579-588.
|
|
[43]FUJII M, SHIBAZAKI Y, WAKAMATSU K, et al.A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma[J].Med Mol Morphol, 2013, 46 (3) :141-152.
|
|
[44]WATANABE S, HORIE Y, KATAOKA E, et al.Non-alcoholic steatohepatitis and hepatocellular carcinoma:lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN) -deficient mice[J].J Gastroenterol Hepatol, 2007, 22 (suppl 1) :s96-s100.
|
|
[45]SHEN J, TSOI H, LIANG Q, et al.Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma[J].Oncogene, 2016, 35 (49) :6271-6280.
|
DownLoad: